Literature DB >> 10339602

Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.

G Rizzuto1, M Cappelletti, D Maione, R Savino, D Lazzaro, P Costa, I Mathiesen, R Cortese, G Ciliberto, R Laufer, N La Monica, E Fattori.   

Abstract

We show that an electric treatment in the form of high-frequency, low-voltage electric pulses can increase more than 100-fold the production and secretion of a recombinant protein from mouse skeletal muscle. Therapeutical erythopoietin (EPO) levels were achieved in mice with a single injection of as little as 1 microgram of plasmid DNA, and the increase in hematocrit after EPO production was stable and long-lasting. Pharmacological regulation through a tetracycline-inducible promoter allowed regulation of serum EPO and hematocrit levels. Tissue damage after stimulation was transient. The method described thus provides a potentially safe and low-cost treatment for serum protein deficiencies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10339602      PMCID: PMC26896          DOI: 10.1073/pnas.96.11.6417

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Muscle maturation: implications for gene therapy.

Authors:  J C van Deutekom; E P Hoffman; J Huard
Journal:  Mol Med Today       Date:  1998-05

2.  Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine.

Authors:  K Anwer; M Shi; M F French; S R Muller; W Chen; Q Liu; B L Proctor; J Wang; R J Mumper; A Singhal; A P Rolland; H W Alila
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

3.  In vivo electrically mediated protein and gene transfer in murine melanoma.

Authors:  M P Rols; C Delteil; M Golzio; P Dumond; S Cros; J Teissie
Journal:  Nat Biotechnol       Date:  1998-02       Impact factor: 54.908

4.  Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.

Authors:  L Qin; Y Ding; D R Pahud; E Chang; M J Imperiale; J S Bromberg
Journal:  Hum Gene Ther       Date:  1997-11-20       Impact factor: 5.695

Review 5.  Erythropoietin therapy.

Authors:  L T Goodnough; T G Monk; G L Andriole
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

6.  Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts.

Authors:  D Bohl; N Naffakh; J M Heard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

7.  Spatial-temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA.

Authors:  S G Doh; H L Vahlsing; J Hartikka; X Liang; M Manthorpe
Journal:  Gene Ther       Date:  1997-07       Impact factor: 5.250

8.  Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector.

Authors:  E C Svensson; H B Black; D L Dugger; S K Tripathy; E Goldwasser; Z Hao; L Chu; J M Leiden
Journal:  Hum Gene Ther       Date:  1997-10-10       Impact factor: 5.695

9.  Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

Authors:  P D Kessler; G M Podsakoff; X Chen; S A McQuiston; P C Colosi; L A Matelis; G J Kurtzman; B J Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

10.  Regulation of gene expression in vivo following transduction by two separate rAAV vectors.

Authors:  K G Rendahl; S E Leff; G R Otten; S K Spratt; D Bohl; M Van Roey; B A Donahue; L K Cohen; R J Mandel; O Danos; R O Snyder
Journal:  Nat Biotechnol       Date:  1998-08       Impact factor: 54.908

View more
  53 in total

1.  The organization of the Golgi complex and microtubules in skeletal muscle is fiber type-dependent.

Authors:  E Ralston; Z Lu; T Ploug
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery.

Authors:  M Briones; M Singh; M Ugozzoli; J Kazzaz; S Klakamp; G Ott; D O'Hagan
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

Review 3.  Vectors for gene therapy of cardiovascular disease.

Authors:  J F Dedieu; A Mahfoudi; A Le Roux; D Branellec
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

4.  Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.

Authors:  Vainav Patel; Antonio Valentin; Viraj Kulkarni; Margherita Rosati; Cristina Bergamaschi; Rashmi Jalah; Candido Alicea; Jacob T Minang; Matthew T Trivett; Claes Ohlen; Jun Zhao; Marjorie Robert-Guroff; Amir S Khan; Ruxandra Draghia-Akli; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

5.  Gene transfer to intact mesenteric arteries by electroporation.

Authors:  J B Martin; J L Young; J N Benoit; D A Dean
Journal:  J Vasc Res       Date:  2000 Sep-Oct       Impact factor: 1.934

6.  Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

Authors:  S Zucchelli; S Capone; E Fattori; A Folgori; A Di Marco; D Casimiro; A J Simon; R Laufer; N La Monica; R Cortese; A Nicosia
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Development of murine embryos following electroporation.

Authors:  C A Schmotzer; M E Dunlap-Brown; S P Butler; W H Velander; F C Gwazdauskas
Journal:  J Assist Reprod Genet       Date:  2003-04       Impact factor: 3.412

8.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

9.  Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation.

Authors:  Jinyan Liu; Rune Kjeken; Iacob Mathiesen; Dan H Barouch
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

Review 10.  Immunogenicity of DNA- and recombinant protein-based Alzheimer disease epitope vaccines.

Authors:  Hayk Davtyan; Andrew Bacon; Irina Petrushina; Karen Zagorski; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Hum Vaccin Immunother       Date:  2014-02-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.